‌

US Patent 11351510 Microfluidic devices

Patent 11351510 was granted and assigned to Bio-Rad Laboratories on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Bio-Rad Laboratories

0

Current Assignee

Bio-Rad Laboratories

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Darren Roy Link0

David Marran0

Jonathan M. Rothberg0

Michael Weiner0

Date of Patent

June 7, 2022

0

Patent Application Number

159962530

Date Filed

June 1, 2018

0

Patent Citations

US Patent 10151698 Selection by compartmentalized screening

US Patent 10155207 Methods for forming mixed droplets

US Patent 10351905 Digital analyte analysis

US Patent 10357772 Manipulation of fluids, fluid components and reactions in microfluidic systems

US Patent 10428369 Analyzing microdroplet outline size and adjusting channel pressure to alter microdroplet size

US Patent 10011865 Systems for handling microfluidic droplets

US Patent 10041113 Apparatus, system, and method using immiscible-fluid-discrete-volumes

US Patent 10052605 Method of synthesis and testing of combinatorial libraries using microcapsules

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

The present invention provides novel microfluidic substrates and methods that are useful for performing biological, chemical and diagnostic assays. The substrates can include a plurality of electrically addressable, channel bearing fluidic modules integrally arranged such that a continuous channel is provided for flow of immiscible fluids.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11351510 Microfluidic devices

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.